Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Global | Publication | November 18, 2016
The Internal Revenue Service (“IRS”) has extended the deadline for furnishing some, but not all, 2016 information reports required by the Patient Protection and Affordable Care Act (“ACA”).
In IRS Notice 2016-70, the IRS extended the deadline for furnishing to individuals 2016 Forms 1095-B and 1095-C from January 31, 2017 to March 2, 2017. These forms provide information to individuals about offers of health coverage and coverage provided. The IRS also extended the good faith transitional relief penalties related to these 2016 information-reporting forms.
However, the IRS did not extend the deadlines for filing the 2016 Forms 1094-B, 1095-B, 1094-C and 1095-C with the IRS. The deadline for filing these forms with the IRS remains February 28, 2017, if not filed electronically, or March 31, 2017, if filed electronically. The IRS did not change the provisions regarding automatic extensions of time for filing certain returns, which remain available.
In light of the recent election, the fate of the ACA remains unclear. However, companies are encouraged to continue compliance with the law while it remains in effect.
Read the full text of IRS Notice 2016-70 here.
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023